ArticleBMC immunology2025

Cyanidin-3-O-glucoside-mediated reduction of regulatory T cells: a therapeutic strategy for multiple myeloma.

Huixian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.